BioSig Technologies, Inc. (BSGM)

NASDAQ: BSGM · IEX Real-Time Price · USD
0.740
-0.030 (-3.87%)
At close: Jan 27, 2023, 4:00 PM
0.750
+0.010 (1.30%)
After-hours: Jan 27, 2023, 5:01 PM EST
-3.87%
Market Cap 42.00M
Revenue (ttm) 159,000
Net Income (ttm) -28.87M
Shares Out 56.76M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 163,084
Open 0.780
Previous Close 0.770
Day's Range 0.710 - 0.790
52-Week Range 0.251 - 1.910
Beta 1.23
Analysts Buy
Price Target 3.83 (+417.57%)
Earnings Date Feb 13, 2023

About BSGM

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial... [Read more]

Industry Medical Devices
Sector Healthcare
CEO Mr. Kenneth Londoner
Employees 50
Stock Exchange NASDAQ
Ticker Symbol BSGM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for BSGM stock is "Buy." The 12-month stock price forecast is $3.83, which is an increase of 417.57% from the latest price.

Price Target
$3.83
(417.57% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology

Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented a...

2 weeks ago - GlobeNewsWire

Update: BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Hear...

1 month ago - GlobeNewsWire

BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Hear...

1 month ago - GlobeNewsWire

BioSig's PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

Clinical abstract focuses on value of PURE EP™'s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation Clinical abstract focuses on value of PURE EP™'s and its groundbr...

1 month ago - GlobeNewsWire

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress Company to introduce its novel digital signal processing technol...

3 months ago - GlobeNewsWire

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

Leading medical center in San Antonio acquires BioSig's novel digital signal processing technology for arrhythmia care Leading medical center in San Antonio acquires BioSig's novel digital signal proc...

4 months ago - GlobeNewsWire

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic's Global EP Summit 2022, a world-class leadership symposium Company to introduce the most advan...

4 months ago - GlobeNewsWire

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Other symbols: BJDXSTSS
5 months ago - Benzinga

(BSGM), (OPFI) – 3 Stocks Under $3 Insiders Are Buying

The Dow Jones closed lower by more than 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Other symbols: OPFIWLMS
5 months ago - Benzinga

(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying

U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Other symbols: LDIOPFIRELI
5 months ago - Benzinga

BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth

Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...

5 months ago - GlobeNewsWire

BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence

Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...

5 months ago - GlobeNewsWire

BioSig's Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022

Leading Medical Center of Excellence Physician will discuss integrating the PURE EP™ System into their practice and procedural workflow Leading Medical Center of Excellence Physician will discuss inte...

5 months ago - GlobeNewsWire

BioSig Sees Positive Momentum from Sales Pipeline Growth

Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...

5 months ago - GlobeNewsWire

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

Led by Dhanunjaya DJ Lakkireddy, MD., the study will investigate expanded applications for the signals acquired by BioSig's PURE EP(T.M.) System Led by Dhanunjaya DJ Lakkireddy, MD., the study will in...

6 months ago - GlobeNewsWire

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...

7 months ago - GlobeNewsWire

BioSig Announces Closing of Public Offering of Common Stock

Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering gre...

7 months ago - GlobeNewsWire

BioSig Announces Pricing of Public Offering of Common Stock

Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering gre...

7 months ago - GlobeNewsWire

BioSig Announces Proposed Public Offering of Common Stock

Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proce...

7 months ago - GlobeNewsWire

BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide

Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering gre...

8 months ago - GlobeNewsWire

BioSig's PURE EP™ System to be Featured During EPLive 2022

The Company's flagship technology to be featured during a two-day educational conference that draws the world's top cardiac electrophysiology experts The Company's flagship technology to be featured d...

8 months ago - GlobeNewsWire

BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements

Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gre...

9 months ago - GlobeNewsWire

BioSig to Present at Heart Rhythm 2022

Company's conference program to include physician presentations and technology demonstrations, including features of its newly released PURE EP(TM) Nova-5 Software Company's conference program to incl...

10 months ago - GlobeNewsWire

BioSig to Present at NobleCon18 Capital Markets Conference

Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing plat...

10 months ago - GlobeNewsWire